CO6491080A2 - Anillo vaginal de gradiente multi-capa - Google Patents

Anillo vaginal de gradiente multi-capa

Info

Publication number
CO6491080A2
CO6491080A2 CO12011321A CO12011321A CO6491080A2 CO 6491080 A2 CO6491080 A2 CO 6491080A2 CO 12011321 A CO12011321 A CO 12011321A CO 12011321 A CO12011321 A CO 12011321A CO 6491080 A2 CO6491080 A2 CO 6491080A2
Authority
CO
Colombia
Prior art keywords
vaginal ring
layer gradient
application
pharmaceutically active
layer
Prior art date
Application number
CO12011321A
Other languages
English (en)
Spanish (es)
Inventor
Bruce Variano
Jeffrey Speck
Maria Teresa Sallent
Simone Evans
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of CO6491080A2 publication Critical patent/CO6491080A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CO12011321A 2009-07-21 2012-01-25 Anillo vaginal de gradiente multi-capa CO6491080A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27139109P 2009-07-21 2009-07-21

Publications (1)

Publication Number Publication Date
CO6491080A2 true CO6491080A2 (es) 2012-07-31

Family

ID=42236498

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12011321A CO6491080A2 (es) 2009-07-21 2012-01-25 Anillo vaginal de gradiente multi-capa

Country Status (14)

Country Link
US (1) US8753667B2 (en:Method)
EP (1) EP2456421B1 (en:Method)
JP (1) JP5690826B2 (en:Method)
CN (1) CN102497855B (en:Method)
AU (1) AU2010274946B2 (en:Method)
BR (1) BR112012001353B8 (en:Method)
CA (1) CA2767967C (en:Method)
CO (1) CO6491080A2 (en:Method)
DK (1) DK2456421T3 (en:Method)
ES (1) ES2626156T3 (en:Method)
IN (1) IN2012DN00711A (en:Method)
MX (1) MX2012000948A (en:Method)
WO (1) WO2011011099A1 (en:Method)
ZA (1) ZA201200809B (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE202011110355U1 (de) * 2011-03-09 2014-01-15 Arstat, Inc. Behandlung von Uterusmyomen durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes
FR3005417B1 (fr) * 2013-05-10 2015-05-22 Blaise Francois Figuereo Anneau vaginal tri-reservoir, a retro-largage compatible avec les caracteristiques des molecules actives qu'il contient
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
DK2982352T3 (en) 2014-06-28 2018-11-26 Laboratorios Andromaco S A CERVICALLY PESSAR CONTAINING PROGESTERON FOR EXTENDED, LONG AND CONTINUOUS RELEASE USED TO PREVENT EARLY BIRTHS
US9943146B2 (en) 2015-05-27 2018-04-17 Qalo Llc Compression molded silicone ring
WO2017011571A1 (en) * 2015-07-14 2017-01-19 Qalo Llc Compression molded silicone ring
WO2017108676A1 (en) * 2015-12-21 2017-06-29 Bayer Oy Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
CN106913412B (zh) * 2017-03-01 2023-09-22 上海市嘉定区妇幼保健院 易放易取式子宫托
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
CA3087410A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
EP4057994A4 (en) * 2019-11-12 2023-12-06 Poly-Med Inc. Contraceptive medical devices
DE102021100916A1 (de) 2021-01-18 2022-07-21 Carl Freudenberg Kg Verfahren zur Herstellung eines Bauteils, Werkzeug zur Durchführung des Verfahrens und Bauteil, das durch das Verfahren hergestellt ist
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL152819B (nl) 1949-04-07 Swift & Co Werkwijze voor het continu bereiden van mono-ammoniumdiwaterstoffosfaatdeeltjes en zo verkregen deeltjes.
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (en:Method) 1953-11-19
GB804199A (en) 1955-12-22 1958-11-12 Midland Silicones Ltd Organosiloxane compositions
GB798669A (en) 1956-12-12 1958-07-23 Midland Silicones Ltd Improvements in or relating to organosiloxane elastomer foams
US2927907A (en) 1957-01-07 1960-03-08 Dow Corning Siloxane elastomers
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3035016A (en) 1959-03-16 1962-05-15 Dow Corning Acyloxy siloxanes and a method of using the
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4596576A (en) 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
FR2598652B1 (fr) 1986-05-16 1988-08-05 Figuereo Blaise Machine d'extrusion simultanee de plusieurs matieres
US4922928A (en) 1988-08-17 1990-05-08 Michael Burnhill Vaginal device
ATE207736T1 (de) 1995-07-04 2001-11-15 Akzo Nobel Nv Ringförmige vorrichtung
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
WO2002076426A2 (en) 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
US7824383B2 (en) 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method

Also Published As

Publication number Publication date
CN102497855A (zh) 2012-06-13
IN2012DN00711A (en:Method) 2015-06-19
ZA201200809B (en) 2012-10-31
BR112012001353B1 (pt) 2020-04-14
MX2012000948A (es) 2012-02-28
US8753667B2 (en) 2014-06-17
CA2767967C (en) 2014-10-21
EP2456421A1 (en) 2012-05-30
JP2012533401A (ja) 2012-12-27
AU2010274946B2 (en) 2013-09-12
US20120148655A1 (en) 2012-06-14
BR112012001353B8 (pt) 2021-05-25
BR112012001353A2 (pt) 2016-04-05
CA2767967A1 (en) 2011-01-27
CN102497855B (zh) 2013-12-25
JP5690826B2 (ja) 2015-03-25
WO2011011099A1 (en) 2011-01-27
ES2626156T3 (es) 2017-07-24
AU2010274946A1 (en) 2012-03-01
EP2456421B1 (en) 2017-04-05
HK1169614A1 (en) 2013-02-01
DK2456421T3 (en) 2017-06-06

Similar Documents

Publication Publication Date Title
CO6491080A2 (es) Anillo vaginal de gradiente multi-capa
CL2020002695A1 (es) Péptidos macrocíclicos contra actinetobacter baumannii
AR083561A1 (es) Preparacion de una construccion antigenica
MX373666B (es) Compensador de grosor de tejido que comprende una pluralidad de capsulas.
CO6612270A2 (es) Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo
CR20130607A (es) Estructura tubular y método para fabricarla
CO6660502A2 (es) Compuestos macrocíclicos como inhibidores de quinasa trk
MX354144B (es) Metodo, fabricacion y uso de productos medicos que liberan sustancia activa para mantener vasos sanguineos abiertos.
BR112013019223A2 (pt) forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
EP2762012A4 (en) SMALL MOLECULE ACTIVE DONKEY GELATIN MIXTURE AND PREPARATION METHOD AND APPLICATION THEREOF
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
CR20160518A (es) Compuestos para tratar atrofia muscular espinal
CR20110134A (es) Compuestos con anillos espiro-tricíclicos como moduladores de Beta-secretasas y métodos de uso
BRPI0913724B8 (pt) formas farmacêuticas de liberação prolongada compreendendo naltrexona e poli (e-caprolactona) e seu preparo
CR20120585A (es) Una forma cristalina de (r)-7cloro-n-(quinuclidin-3-il) benzo [b] tiofeno-2-carboxamida monohidrato
ECSP14007473A (es) COMPOSICIONES FARMACÉUTICAS DE 7-(6-(2-HIDROXIPROPAN-2-IL) PIRIDIN-3-IL)-1-( (TRANS)-4METOXICICLOHEXIL)-3, 4-DIHIDROPIRAZINO [2, 3-b] PIRAZIN-2 (1H)-ONA, UNA FORMA SÓLIDA DE LAS MISMAS Y MÉTODOS DE SU USO
ECSP11011558A (es) Nuevos compuestos químicos.
CR20110210A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
ECSP19026973A (es) Derivados de naftiridinona y su uso en el tratamiento de la arritmia
DOP2009000285A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulacion sanguinea.
CL2015001187A1 (es) Compuestos derivados de azaquinolin-carboxamida, como inhibidores de p70s6k; su metodo de manufactura; composicion farmaceutica que los comprende; y su uso para el tratamiento profilactico o terapeutico de trastornos hiperproliferativos, cancer, retinopatia diabetica, dolor, eczema y degeneracion macular relacionada con la edad, entre otras enfermedades.
CL2013003036A1 (es) Formulaciones topicas de tipo suspencion que comprende un depsipeptido ciclico; un metodo de tratamiento para una enfermedad dermatologica, tal como enfermedades inflamatorias y/o hiperproliferativas seleccionadas de rosacea, queloides, psoriasis, entre otras.
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo

Legal Events

Date Code Title Description
FG Application granted